SCMP Financial Facts
Comprehensive income (loss): 12.74MSelling and marketing: 696K
See Full Income Statement
Total current assets: 237.48M
Accumulated other comprehensive income: 54.34M
See Full Balance Sheet
Sucampo Pharmaceuticals (SCMP) Earnings
|
Expand Research on SCMP
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -2.4% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -0.1% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/1/17 |  |
Q317 | $0.27 | $0.25 | +$0.02 | $61.3M | $58.05M |  |
 | | Details |
| 8/2/17 | |
Q217 | $0.28 | $0.27 | +$0.01 | $59.9M | $56.43M | |
| | Details |
| 5/3/17 | |
Q117 | $0.10 | $0.27 | -$0.17 | $56.3M | $54.14M | |
| | Details |
| 3/8/17 | Q416 | $0.68 | $0.48 | +$0.20 | $73M | $66M | |
| | Details | |
11/9/16  |
|
Q316 | $0.28 | $0.26 | +$0.02 | $57.9M | $51.46M | |
| | Details |
| 8/3/16 |
|
Q216 | $0.23 | $0.22 | +$0.01 | $52M | $48.61M | |
| | Details |
| 5/4/16 |
|
Q116 | $0.21 | $0.19 | +$0.02 | $47.2M | $44.11M | |
| | Details |
| 3/8/16 |
|
Q415 | $0.43 | $0.19 | +$0.24 | $55.4M | $42.72M | |
| | Details |
